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Imprinted genes are differentially expressed by adult
stem cells, but their functions in regulating adult
stem cell fate are incompletely understood. Here
we show that growth factor receptor-bound protein
10 (Grb10), an imprinted gene, regulates hematopoi-
etic stem cell (HSC) self-renewal and regeneration.
Deletion of the maternal allele of Grb10 in mice
(Grb10m/+ mice) substantially increased HSC long-
term repopulating capacity, as compared to that of
Grb10+/+ mice. After total body irradiation (TBI),
Grb10m/+ mice demonstrated accelerated HSC
regeneration and hematopoietic reconstitution, as
compared to Grb10+/+ mice. Grb10-deficient HSCs
displayed increased proliferation after competitive
transplantation or TBI, commensurate with upregula-
tion of CDK4 and Cyclin E. Furthermore, the
enhanced HSC regeneration observed inGrb10-defi-
cient mice was dependent on activation of the Akt/
mTORC1 pathway. This study reveals a function for
the imprinted gene Grb10 in regulating HSC self-
renewal and regeneration and suggests that the
inhibition of Grb10 can promote hematopoietic
regeneration in vivo.INTRODUCTION
Hematopoietic stem cell (HSC) self-renewal is regulated by
intrinsic mechanisms and extrinsic signals emanating from the
bone marrow (BM) microenvironment or niche (Zon, 2008; Mor-
rison and Scadden, 2014; Mendelson and Frenette, 2014).
A fundamental property of HSCs is the capacity to regenerate
following various genotoxic stresses, including ionizing radia-
tion, chemotherapy, and inflammatory processes. However,1584 Cell Reports 17, 1584–1594, November 1, 2016 ª 2016 The Au
This is an open access article under the CC BY-NC-ND license (http://the mechanisms that govern HSC regeneration are not well un-
derstood (Mendelson and Frenette, 2014; Zhao et al., 2014; Him-
burg et al., 2010, 2012; Doan et al., 2013; Hooper et al., 2009;
Poulos et al., 2013). Several imprinted genes have been shown
to be essential for normal development, and imprinted genes
have been postulated to have an important role in regulating
adult stem cell fate (Berg et al., 2011; Wood and Oakey, 2006;
Tycko and Morison, 2002). However, few imprinted genes have
been shown to have a role in regulating adult stem cell function
(Ferro´n et al., 2011; Zacharek et al., 2011; Venkatraman et al.,
2013; Qian et al., 2016).
To identify candidate genes that regulate HSC regeneration,
we performed gene expression analysis of purified murine BM
HSCs in steady state and following myeloablative total body
irradiation (TBI). Via comprehensive gene expression analysis,
we discovered that the expression of an imprinted gene,
Grb10, was substantially increased in regenerating BM HSCs
compared to steady-state HSCs. Expression of the paternal
allele of Grb10 is restricted to the nervous system, whereas
the maternal allele of Grb10 is expressed in most non-neuronal
tissues (Plasschaert and Bartolomei, 2015). Grb10 encodes for
an adaptor protein that regulates signaling through multiple
tyrosine kinases, and it is most well characterized as an inhibitor
of insulin receptor (IR) and insulin-like growth factor 1 receptor
(IGF1R) signaling in adipose tissue and muscle (Smith et al.,
2007; Charalambous et al., 2003; Vecchione et al., 2003; Liu
et al., 2014). Of note, biochemical analyses suggest that
Grb10 also may bind tyrosine kinases that are expressed by
HSCs, including c-kit and VEGFR (Holt and Siddle, 2005), but
the functional role of Grb10 in regulating HSC fate has not
been established.
Here we show that Grb10 regulates HSC self-renewal and
regeneration following injury. Maternal deletion of Grb10
markedly increased HSC self-renewal in vivo following compet-
itive transplantation, and it also promoted HSC regeneration
following TBI. Furthermore, the augmentation in HSC regenera-
tion that we observed inGrb10-deficient micewas dependent on
activation of the Akt/mTORC1 pathway. These data reveal anthors.
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Grb10 Expression Is Increased in Regenerating BM HSCs
(A) Left: representative flow cytometry analysis of BM KSL cells in non-irradiated, adult C57BL/6 mice and at day +7 and day +14 following 550 cGy TBI. Right:
mean numbers of BM KSL cells/femur are shown over time following TBI (n = 8/group, means ± SEM).
(B) The heatmap shows the genes whose expression was most highly up- or downregulated following 550 cGy TBI (n = 6 mice/sample, six samples/group). Red,
increased expression; green, decreased expression.
(C) Mean expression of Grb10 by qRT-PCR analysis of BM KSL cells or c-kit+sca-1lin progenitor cells in non-irradiated mice and at day +14 following 550 cGy
TBI is shown (n = 6/group; ns, not significant).
(legend continued on next page)
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inhibitory role for the imprinted gene, Grb10, in regulating HSC
self-renewal and regeneration.
RESULTS
Grb10 Is Differentially Expressed by Regenerating HSCs
To identify candidate genes that regulate HSC regeneration, we
compared the gene expression of BM c-kit+sca-1+lineage
(KSL) cells in non-irradiated mice with that of BM KSL cells
isolated from mice at day +14 following 550 cGy TBI. We
selected the day +14 time point because this was the earliest
time point at which BM KSL cells were readily detectable by
flow cytometry following myeloablative TBI (Figure 1A). Gene
expression analysis of KSL cells at this time point revealed
several genes that were upregulated and downregulated in
expression compared to KSL cells in steady state (Figure 1B;
Table S1). The expression of Grb10 was 5.5-fold higher in irradi-
ated BM KSL cells compared to non-irradiated KSL cells
(Figure 1C). Conversely, Grb10 expression was not altered in
lineage-committed c-kit+sca-1lin myeloid progenitor cells,
suggesting an HSC-specific alteration of Grb10 expression in
response to irradiation. Interestingly, Grb10 expression was
highest in BM CD34KSL cells, which are enriched for long-
term HSCs (LT-HSCs), compared to whole BM or committed
progenitor cells (Figure 1D).
We next sought to determine whether specific transcription
factors were involved in regulating the expression of Grb10 in
HSCs. STAT5b and LMX1a are transcription factors that have
been suggested to bind to or regulate the expression of Grb10
(Hoekstra et al., 2013; Cowley et al., 2014). We found that
LMX1a was not expressed by BM CD34KSL cells in steady
state or following 550 cGy irradiation, but STAT5b was ex-
pressed by BM KSL cells and increased in expression following
550 cGy (Figure 1E). Further, when we suppressed STAT5b
expression in BM CD34KSL cells via STAT5b-small interfering
RNA (siRNA), we observed a significant reduction in Grb10
expression (Figure 1F). Taken together, these data suggested
that STAT5b regulated the expression of Grb10 in BM
CD34KSL cells and likely contributed to Grb10 upregulation
in response to irradiation.
Maternal Deletion ofGrb10 IncreasesHSCRepopulating
Capacity
To test whether Grb10 regulates hematopoiesis, we obtained
Grb10 gene trap mutant mice (Grb10D2-4mice) (Charalambous
et al., 2003) and extensively backcrossed this strain into the
C57BL/6 strain. Paternal inheritance of Grb10D2-4 (Grb10+/p
mice) caused no significant alteration in Grb10 expression in
BM cells, but it caused significantly decreased expression in
the brain (Figure S1A). In contrast, maternal inheritance of
Grb10D2-4 (Grb10m/+ mice) caused significantly decreased
expression of Grb10 in BM hematopoietic lineage– cells, with(D) Mean expression of Grb10 in BM CD34KSL HSCs, KSL stem/progenito
(n = 6–10 mice/group). WBM, whole bone marrow cells.
(E) Expression of Grb10, STAT5b, and LMX1a in BM CD34KSL cells in steady s
(F) Expression of STAT5b (left) and Grb10 (right) in BM CD34KSL cells at da
(n = 6/group) (all panels, means ± SEM). See also Table S1.
1586 Cell Reports 17, 1584–1594, November 1, 2016no effect on expression in the brain (Figure S1A). We therefore
focused on evaluating the effect of maternal inheritance of
Grb10D2-4 on the hematopoietic system.
Adult Grb10m/+ mice displayed moderately increased periph-
eral blood (PB) white blood counts (WBCs), hemoglobin, platelet
counts, and Mac-1+ myeloid cells compared to Grb10+/+ mice
(Figure 2A; Figure S1B). Interestingly, Grb10m/+ mice also dis-
played increased percentages of eythroid progenitors (EPs),
red blood cell counts, and megakaryotic progenitors (MkPs) in
steady state compared toGrb10+/+mice (Figure 2B; Figure S1C).
However, no differences were observed in spleen sizes
compared to Grb10+/+ littermates. No significant differences
were observed in BM cell counts, BM KSL cells, or SLAM+KSL
HSCs between Grb10m/+ mice and Grb10+/+ littermates (Fig-
ure 2C; Figure S1D). However, Grb10m/+ mice contained signifi-
cantly increased BM colony-forming cells (CFCs, Figure 2C).
Furthermore, mice transplanted competitively with 5 3 104 BM
cells from Grb10m/+ mice, along with 23 105 host BM cells, dis-
played 6-fold increased donor-derived, multilineage hemato-
poietic cell repopulation in the PB through 20 weeks post-trans-
plantation (Figures 2D–2F; Figure S1E). Mice competitively
transplanted with BM cells from Grb10m/+ mice had increased
donor cell contribution to BM SLAM+KSL HSCs compared
to mice transplanted with BM from Grb10+/+ mice (Figure 2E).
Recipients of BM cells from Grb10m/+ mice also displayed
increased donor-derived multipotent progenitor cells (MPPs)
and megakaryocytic-erythroid progenitors (MEPs) compared
to recipients of Grb10+/+ BM cells (Figure 2F).
Secondary competitive repopulation assays in which recipient
mice were transplanted with 3 3 106 BM cells from primary
recipient mice showed that Grb10m/+ BM cells provided signifi-
cantly increased, long-term multilineage hematopoietic repopu-
lation compared to Grb10+/+ BM cells (Figure 2G). These data
suggested that maternal deletion of Grb10 substantially
increased the long-term repopulating capacity of HSCs. Of
note, primary recipients of competitively transplanted BM cells
from Grb10m/+ mice displayed moderately increased B cell dif-
ferentiation relative to myeloid cell differentiation at 20 weeks
after transplantation, but this lineage skewing was not evident
in secondary transplanted mice (Figures S1F and S1G).
Grb10 Deletion Promotes HSC Regeneration after
Irradiation
Since the expression of Grb10 increased in HSCs during recov-
ery from TBI, we sought to determine if Grb10 regulated HSC
regeneration in mice. At day +10 following 550 cGy TBI, a mye-
losuppressive but sublethal radiation dose, Grb10m/+ mice
displayed increased recovery of BM cell counts, KSL cells,
SLAM+KSL HSCs, CFCs, and erythroid progenitors compared
to Grb10+/+ mice (Figures 3A–3D). Furthermore, mice that
were competitively transplanted with BM cells collected at
day +10 from irradiated,Grb10m/+ mice displayed8-fold higherrs, and other committed hematopoietic populations by qRT-PCR is shown
tate and at day +10 following 550 cGy TBI is shown (n = 6/group).
y +3 following treatment with siRNA-STAT5b or scramble siRNA is shown
Figure 2. Maternal Deletion of Grb10 Increases HSC Repopulating Capacity
(A) Scatterplots of PB white blood counts (WBCs), hemoglobin (Hb), and platelet counts (PLTs) in 8-week-old Grb10m/+ mice and Grb10+/+ mice are shown
(n = 8–10 mice/group).
(B) Mean percentages of erythroid progenitors (EPs) and megakaryocyte progenitors (MkPs) in Grb10m/+ mice and Grb10+/+ mice are shown (n = 8/group).
(C) Mean BM cell counts, KSL cells, SLAM+KSL cells, and CFCs in Grb10m/+ mice and Grb10+/+ mice are shown (n = 6–12/group). GEMM, colony-forming unit-
granulocyte erythroid monocyte megakaryocyte; BFU-E, burst-forming unit-erythroid; GM, colony-forming unit-granulocyte macrophage.
(D) Donor (CD45.2+) cell engraftment over time in recipient CD45.1+ mice transplanted with 53 104 BM cells fromGrb10m/+ mice orGrb10+/+ mice, together with
2 3 105 CD45.1+ competitor BM cells, is shown (n = 8/ group; p = 0.007, p = 0.001, p = 0.003, and p = 0.006 for 8, 12, 16, and 20 weeks, respectively, Mann-
Whitney test).
(legend continued on next page)
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multilineage donor hematopoietic cell repopulation through
20 weeks post-transplantation compared to mice transplanted
with BM cells from identically irradiated Grb10+/+ mice (Figures
3E and 3F). These results suggested that deletion of Grb10
accelerated the regeneration of long-term repopulating HSCs
and progenitor cells following TBI.
Grb10 Deletion Increases Hematopoietic Stem/
Progenitor Cell-Proliferative Potential
Since Grb10-deficient HSCs displayed increased self-renewal
capacity following competitive transplantation and following ra-
diation injury, we sought to determine the cellular mechanism
responsible for these effects. We observed no differences in
BM SLAM+KSL cell proliferation or survival of BM KSL cells
between Grb10m/+ mice and Grb10+/+ mice in steady state (Fig-
ure S2A). Further, we observed no difference in the homing ca-
pacity of transplanted Grb10m/+ BM sca-1+lin cells compared
to Grb10+/+ BM sca-1+lin cells (Figure S2A). However, at
48 hr following transplantation, we observed significantly
increased BrdU incorporation in transplanted Grb10m/+ cells in
the BM of recipient mice compared to Grb10+/+ BM cells (Fig-
ure 4A). These data suggested that Grb10 deletion primed trans-
planted BM cells to proliferate more rapidly following homing to
the BM niche.
Following in vitro irradiation with 300 cGy, increased percent-
ages of KSL cells from Grb10m/+ mice were in G1 and G2/S/M
phases compared to KSL cells from Grb10+/+ mice (Figure 4B).
In vivo, at 24 hr following 700 cGy irradiation, Grb10m/+ mice
also displayed increased percentages of BM KSL cells in G1
and G2/S/M phases compared to Grb10
+/+ mice (Figure S2B).
Conversely, no differences were observed in the apoptosis of
BM KSL cells from Grb10m/+ mice or Grb10+/+ following 300
cGy irradiation in vitro or 700 cGy in vivo (Figure 4C; Figure S2C).
Nonetheless, CFC recovery from BM KSL cells from Grb10m/+
mice following 300 cGy was significantly increased compared
to irradiated KSL cells from Grb10+/+ mice (Figure 4D). Taken
together, these results suggested that BM KSL cells from
Grb10m/+ mice possessed increased proliferative potential
following injury. Consistent with this observation, we detected
increased expression of the cyclin-dependent kinase (CDK)4
and Cyclin E in BM KSL cells in Grb10m/+ mice at 3 hr following
300 cGy irradiation (Figure 4E). We observed no differences in
the expression of cyclin dependent kinase (CDK) inhibitors be-
tween Grb10m/+ BM KSL cells and Grb10+/+ BM KSL cells (Fig-
ure S2D) and also no differences in HSC senescence (Figure 4F)
between these populations after irradiation.
Grb10 Deletion Potentiates HSC Regeneration via
Akt/mTORC1 Activation
Grb10 is an adaptor protein that lacks catalytic function but con-
tains several protein-bindingmotifs that implicate Grb10 inmedi-(E) Left: mean total donor CD45.2+ cells in the PB of recipient CD45.1+ mice at 20
derived HSCs (SLAM+KSL cells) in the BM of recipient mice following competitiv
(F) Mean donor-derived MPPs, CMPs, GMPs, and MEPs in the BM of recipien
Whitney test).
(G) Mean total donor CD45.2+ cells in secondary recipient mice at 12 weeks follo
competitor cells, n = 10–12/group; Mann-Whitney test; all panels, means ± SEM
1588 Cell Reports 17, 1584–1594, November 1, 2016ating interactions between other proteins (Smith et al., 2007).
Grb10 can bind several receptor tyrosine kinases (RTKs),
including IR, IGF1R, and c-kit, and genetic studies have demon-
strated that Grb10 is a negative regulator of insulin and IGF1
signaling in adipose tissue (Charalambous et al., 2003; Smith
et al., 2007; Cao et al., 2008). Grb10 is also a substrate for the
mammalian target of rapamycin (mTOR), and Grb10 negatively
regulates mTORC1 signaling in adipocytes (Yu et al., 2011; Liu
et al., 2014). Interestingly, BM KSL cells from Grb10m/+ mice
showed no increase in Akt or mTORC1 activation in steady state
(Figure S3A). However, following 700 cGy TBI, BMKSL cells from
Grb10m/+ mice displayed significantly increased mTORC1 acti-
vation compared to Grb10+/+ cells (Figure S3B). Similarly, treat-
ment with c-kit ligand (stem cell factor [SCF]) significantly
increased Akt and mTORC1 activation in Grb10m/+ KSL cells
compared to Grb10+/+ KSL cells (Figure S3B). Taken together,
these data suggested that maternal deletion of Grb10 did not
alter baseline Akt or mTORC1 activation in KSL cells, but rather
it potentiated the responsiveness of the Akt/mTORC1 pathway in
BM KSL cells in the setting of stress or cytokine stimulation.
Importantly, irradiated Grb10m/+ mice displayed accelerated re-
covery of BM SLAM+KSL HSCs at day +10 following 550 cGy
TBI, but systemic administration of a specific inhibitor of Akt
(MK2206) or mTORC1 (CCI-779) completely abrogated this
accelerated recovery of HSCs in Grb10m/+ mice (Figure 4G).
These results suggested that the early HSC regeneration
observed in irradiated Grb10m/+ mice was dependent on Akt/
mTORC1 pathway activation.
Since Grb10 has been shown to inhibit IR signaling in adipo-
cytes via binding and inhibition of the catalytic domains of IR
(Liu et al., 2014),wepostulated thatGrb10mightmediate a similar
inhibitory action on the c-kit receptor in HSCs, since c-kit activa-
tion induces Akt/mTORC1 signaling in HSCs (Lennartsson and
Ro¨nnstrand, 2012). Interestingly, treatment of BM KSL cells
from Grb10m/+ mice with SCF produced increased numbers of
CFCs compared to the yield from SCF treatment of KSL cells
fromGrb10+/+mice (Figure4H). Further, aproximity ligationassay
(PLA) (Lu et al., 2012) demonstrated increased binding of Grb10
with c-kit in wild-type BM KSL cells following SCF treatment
(Figure 4I). Conversely, when BM KSL cells from Grb10m/+ mice
were treated with SCF, Grb10 binding to c-kit was markedly
decreased. Taken together, these results suggested that Grb10
bound c-kit in BM hematopoietic stem/progenitor cells (HSPCs)
in response to SCF treatment and that the enhanced Akt/
mTORC1 activation in Grb10-deficient KSL cells may have
been related to the absence of inhibitory Grb10 binding to c-kit.
DISCUSSION
This study reveals a previously unrecognized role for the im-
printed gene Grb10 in regulating adult HSC self-renewal.weeks following competitive transplantation in each group. Right: mean donor-
e transplantation are shown (n = 8/group, Mann-Whitney test).
t mice following competitive transplantation are shown (n = 8/group, Mann-
wing competitive transplantation are shown (3 3 106 donor BM cells, 2 3 105
). See also Figure S1.
Figure 3. Maternal Deletion of Grb10 Promotes HSC Regeneration following Irradiation
(A) Representative H&E-stained femurs from Grb10m/+ mice and Grb10+/+ mice at day +10 following 550 cGy TBI and mean BM cell counts in each group are
shown (n = 8 mice/group; 53 magnification; scale bar, 500 mm).
(B) Mean BM CFCs in Grb10m/+ mice and Grb10+/+ mice at day +10 and day +14 following 550 cGy TBI are shown (n = 6/group).
(C) A representative flow cytometry plot of BMKSL cells and SLAM+KSL cells and numbers of BMKSL cells and SLAM+KSL cells are shown inGrb10+/+ mice and
Grb10m/+ mice at day +10 following 550 cGy TBI (n = 12–14 mice/group; percentages of KSL and SLAM+KSL cells are shown in the gates). Mean values are
represented by horizontal lines.
(D) Mean percentages of EPs and MkPs in Grb10m/+ mice and Grb10+/+ mice at day +10 following 550 cGy TBI are shown (n = 5/group).
(legend continued on next page)
Cell Reports 17, 1584–1594, November 1, 2016 1589
Maternal deletion ofGrb10 substantially increased HSC repopu-
lating capacity as measured in primary and secondary trans-
planted mice, and it also increased the frequencies of BM
erythroid progenitors and megakaryocytic progenitor cells.
These functional results are consistent with the prior observation
by Berg et al. (2011) that Grb10 is differentially expressed in LT-
HSCs and myelo-erythroid progenitor cells. Further, primary
mice transplanted withGrb10m/+ BM cells displayed moderately
increased B lymphoid differentiation and decreased myeloid dif-
ferentiation compared to mice transplanted with Grb10+/+ BM
cells. Taken together, these results suggest that, in addition to
effects on HSC repopulating capacity, Grb10 likely regulates
myeloid differentiation potential.
Our findings regarding Grb10 add significantly to the general
understanding of the function of imprinted genes in adult stem
cells. Recently, two imprinted genes, Cdkn1c (p57) and delta-
like 1 homolog (Dlk1), were found to inhibit the regeneration of
adult lung and muscle stem cells, respectively (Zacharek et al.,
2011; Andersen et al., 2013). Epigenetic silencing of the im-
printed gene Cdkn1c by BMI1 was reported to be necessary
for bronchioalveolar stem cell (BASC) regeneration, and
silencing of Cdkn1c rescued BASC regenerative function (Za-
charek et al., 2011). Similarly, deletion of Dlk1was shown to pro-
mote adult skeletal muscle regeneration in vivo (Andersen et al.,
2013). Conversely, expression of long non-coding RNAs from
the Dlk1-Gtl2 imprinted gene locus was shown to promote
HSC maintenance via the suppression of reactive oxygen spe-
cies (Qian et al., 2016). Another imprinted gene locus, H19-
Igf2, was found to be important for HSC repopulating capacity
and long-term maintenance of quiescent HSCs (Venkatraman
et al., 2013). Here we demonstrate thatGrb10 deletion promotes
HSC repopulating capacity and regeneration in vivo, suggesting
that Grb10 negatively regulates these processes.
We have further demonstrated that Grb10-deficient HSPCs
possess enhanced proliferative potential and regenerative ca-
pacity in vivo following transplantation or radiation injury.
Grb10 expression increased in wild-type BM 34KSL cells and
KSL cells following high-dose irradiation, and siRNA experi-
ments suggested that Grb10 expression in HSCs is under the
control of STAT5b. Interestingly, following radiation injury, BM
KSL cells from Grb10m/+ mice manifested no alterations in
apoptosis or senescence compared toGrb10+/+ mice, but rather
they displayed increased percentages of cells in G2/S/M phase,
concordant with increased expression of CDK4 and Cyclin E.
These results are consistent with the established functions of
CDK4 and Cyclin E in promoting cell cycle entry and G1 to
S phase transition (Mende et al., 2015; Ohtsubo et al., 1995).
Our results further suggest that enhancement of HSC regener-
ation inGrb10-deficient mice is dependent upon the activation of
Akt and mTORC1 signaling. mTORC1 has been shown to pro-
mote cell proliferation via the induction of CDK4 and Cyclin E
expression (Lee et al., 2015). Miao et al. (2016) reported that(E) Donor (CD45.2+) cell engraftment over time in the PB of recipient CD45.1+ mice
following 550 cGy TBI, together with 13 105 CD45.1+ competitor BM cells, is show
8, 12, 16, and 20 weeks, respectively, Mann-Whitney test).
(F) Scatterplots show the percentage donor CD45.2+ cell, KSL cell, Mac-1/Gr-1+
transplantation of irradiated donor BM cells from each group into recipient CD45
1590 Cell Reports 17, 1584–1594, November 1, 2016mTORC1 activation was essential for Akt-mediated axon regen-
eration in the CNS, and Akt/mTORC1 pathway activation has
been shown to promote hepatic regeneration in aged mice (Giel-
chinsky et al., 2010). We found that Grb10 deletion in HSCs did
not alter mTORC1 activation in steady state, but it did augment
mTORC1 signaling in HSCs in response to irradiation or SCF
treatment. Importantly, we have shown that the accelerated
regeneration of HSCs in Grb10-deficient mice was dependent
upon the activation of Akt and mTORC1. In this regard, our find-
ings are consistent with the recently described role for mTORC1
in the adaptive response of muscle stem cells to injury (Rodgers
et al., 2014). SinceGrb10 deletion did not cause constitutive acti-
vation of the mTOR pathway in HSCs, we did not observe
exhaustion of the HSC pool as has been described following
deletion of the mTOR inhibitors phosphatase and tensin homo-
log (PTEN) and the tuberous sclerosis complex 1 (TSC1) (Yilmaz
et al., 2006; Lee et al., 2010; Gan andDePinho, 2009). Rather, our
results support a functional role for mTORC1 signaling in HSC
self-renewal, as was recently suggested by Ghosh et al. (2016).
In summary, we describe a function for the adaptor protein
Grb10 in regulating HSC self-renewal following transplantation
and HSC regeneration in response to injury. Targeted inhibition
of Grb10 has therapeutic potential as a means to promote he-
matopoietic regeneration in the setting of HSC transplantation
or following myelosuppressive injury. For this reason, the long-
term consequences of Grb10 inhibition on the hematopoietic
system of irradiated or transplanted animals will be important
questions to address. Clarification of the effects of Grb10 inhibi-
tion on myeloid differentiation will be particularly critical to
address in pre-clinical studies. In this regard, it is noteworthy
that we have observed no signs of myelodysplasia or leukemia
in Grb10-deficient mice through 1 year of age. Furthermore,
the potency of Grb10 deletion in augmenting HSC self-
renewal and regeneration highlights the potential importance of
pharmacologic agents capable of inhibiting Grb10 as a means
to accelerate hematopoietic recovery in patients receiving
myelosuppressive therapies or undergoing hematopoietic cell
transplantation.
EXPERIMENTAL PROCEDURES
Statistics
Unless stated otherwise in the figure legends, all graphical data are presented
as means ± SEM, except histograms, and significance was calculated using
two-tailed Student’s t test (p < 0.05 was considered significant). Competitive
repopulating assays were compared with a two-tailed Mann-Whitney test.
For all animal studies, we used a power test to determine the sample size
needed for a 2-fold difference in mean with 0.8 power using a two-tailed Stu-
dent’s t test. Animals in our studies were sex- and age-matched and litter-
mates were used as controls.
Mice
All mouse procedures were performed in accordance with UCLA animal
research and oversight committee-approved protocols. Grb10D2-4 micetransplanted with 53 105 BM cells fromGrb10m/+ orGrb10+/+ mice at day +10
n (n = 8–10/group; p = 0.002, p = 0.01, p = 0.001, p = 0.008, and p = 0.03 for 4,
, B220+, and CD3+ engraftment in the BM at 20 weeks following competitive
.1+ mice (n = 8–10/group, Mann-Whitney test; all panels, means ± SEM).
Figure 4. Grb10 Deletion Promotes HSC Regeneration via the Induction of Akt/mTORC1 Signaling
(A) Left: representative flow cytometry plots are shown of BrdU+ donor CD45.2+ BM cells at 48 hr following transplantation of BM cells from Grb10+/+ mice or
Grb10m/+ mice into CD45.1+ recipients. Right: the scatterplot shows the mean percentage of BrdU+ BM cells in each group (n = 6/group).
(B) Mean percentages of Grb10+/+ and Grb10m/+ KSL cells in G0, G1, and G2/S/M phases at 3 hr after 300 cGy in vitro irradiation are shown (n = 6/group).
(C) Mean percentages of Annexin V+ cells in BM KSL cells from Grb10+/+ and Grb10m/+ mice at 3 hr after 300 cGy in vitro irradiation are shown (n = 8/group).
(D) Mean numbers of CFCs from 500 BM KSL cells isolated from Grb10+/+ and Grb10m/+ mice at day +3 following 300 cGy in vitro irradiation are shown
(n = 6/group).
(E) Expression of cyclin-dependent kinases and cyclin proteins in BM KSL cells from Grb10+/+ mice and Grb10m/+ mice at 3 hr after 300 cGy irradiation is shown
(n = 6/group).
(F) Mean percentages of senescence-associated b-galactosidase (SA-b-Gal)-positive CD34KSL cells inGrb10+/+ andGrb10m/+ mice at 24 hr following 700 cGy
TBI are shown (n = 8/group).
(G) Left: representative flow cytometry analysis of SLAM+KSL cells inGrb10+/+ mice andGrb10m/+ mice at day +10 following 550 cGy TBI and treatment with and
without themTORC1 inhibitor CCI-779. Right: scatterplot shows the numbers of BMSLAM+KSL cells inGrb10+/+ andGrb10m/+ mice at day +10 following 550 cGy
TBI and treatment with and without CCI-779 or MK2206, an Akt inhibitor (n = 6/group).
(legend continued on next page)
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were a kind gift from Dr. Andrew Ward (University of Bath). Grb10D2-4 mice
were extensively backcrossed into a C57BL/6 background for these studies.
Grb10m/+ mice, Grb10+/+ mice, and Grb10+/p mice were evaluated at
8–12 weeks of age. C57BL/6 mice and B6.SJL mice between 8 and 12 weeks
old were obtained from the Jackson Laboratory.
Microarray Analysis
C57BL/6 mice were irradiated with 550 cGy TBI. At day +14, BM KSL cells
were isolated by fluorescence-activated cell sorting (FACS), as previously
described (Himburg et al., 2014). Genomic RNAs from irradiated BM KSL cells
and non-irradiated KSL cells were isolated and amplified using an RNA ampli-
fication kit (Ovation RNA-Seq System V2, Nugen). Amplified RNA samples
then were loaded onto GeneChip Mouse Genome 430A 2.0 array (Affymetrix).
We analyzed the microarray data with Partek Genomics Suite, and we gener-
ated lists of differentially expressed genes triggered by irradiation, as previ-
ously described (Zheng et al., 2014).
STAT5b siRNA Experiments
BM CD34KSL cells from Grb10m/+ and Grb10+/+ mice were sorted with a BD
ARIA sorter, and they were resuspended in Accell Delivery Medium (Dharma-
con) supplemented with 100 ng/mL SCF (R&D Systems) and 20 ng/mL throm-
bopoietin (TPO, R&D Systems). Accell siRNA (1 mM, Dharmacon) targeting
STAT5b was added to the medium. At 72 hr after siRNA treatment, cells
were collected and qRT-PCR analysis for STAT5b and Grb10 was performed.
Mouse Competitive Repopulation Assays
For primary competitive repopulation assays, BM cells were isolated from 10-
to 12-week-old donor Grb10m/+ mice and Grb10+/+ mice, which express
CD45.2. The 10-week-old recipient CD45.1+ B6.SJL mice were irradiated,
with 950 cGy TBI using a Cs 137 irradiator, 12 hr prior to transplantation.
BM cells (5 3 104) from Grb10m/+ mice or Grb10+/+ mice were injected via
tail vein into recipient mice along with 23 105 host competitor BM cells. Multi-
lineage hematopoietic cell engraftment was measured by flow cytometry
analysis of the PB every 4 weeks through week 20 post-transplantation, as
previously described (Himburg et al., 2014; Quarmyne et al., 2015). For
secondary competitive repopulation assays, 3 3 106 total BM cells from pri-
mary recipient mice were injected via tail vein into irradiated B6.SJL mice
with 2 3 105 host competitor BM cells from the B6.SJL mice. Donor hemato-
poietic cell engraftment was measured by flow cytometry at 4 through
20 weeks post-transplantation.
Flow Cytometry Analysis
BM cells were collected from tibias and femurs and stained with anti-c-kit
phycoerythrin (PE)-Cy7 (BD Biosciences), anti-Sca-1 APC-Cy7 (BD Biosci-
ences), anti-lineage V450 (BD Biosciences), anti-CD48 fluorescein isothiocya-
nate (FITC, BioLegend), anti-CD127 FITC (BD Biosciences), anti-CD41 Alexa
Fluor 488 (BioLegend), anti-CD34 APC (BD Biosciences), anti-CD135 PE
(BD Biosciences), anti-CD16/32 PerCP (BD Biosciences), and anti-CD150
Alexa Fluor 647 (BioLegend). BM HSCs (CD150+CD48LineageSca-1+
c-Kit+), MPPs (CD150CD48LineageSca-1+c-Kit+), common myeloid
progenitors (CMPs) (CD34+CD16/32lowCD127LineageSca-1c-Kit+), gran-
ulocyte monocyte progenitor (GMPs) (CD34+CD16/32highCD127Lineage
Sca-1c-Kit+), MEPs (CD34CD16/32/lowCD127LineageSca-1c-Kit+),
MkPs (CD150+CD41+LineageSca-1c-Kit+), and EPs (CD71+Ter119+) were
stained with the indicated cell surface marker antibodies.
For intracellular phosphoprotein analysis, BM cells were flushed into serum-
free PBS. BM cells were stained with surface marker antibodies, then washed
with PBS and fixed for 15min at 4C, followed by incubation with BD cytoperm
buffer for 30 min at room temperature. Rabbit anti-pS6K (Thr389) (Cell
Signaling Technology) or anti-pAkt PE (Cell Signaling Technology) was added(H) Mean ratios of CFC numbers from BM KSL cells in response to SCF treatmen
from Grb10m/+ mice (n = 6/group).
(I) Left: representative fluorescence microscopic images (633; scale bar, 10 mm
Grb10+/+ mice and Grb10m/+ mice following 15 min of SCF treatment. Blue, DAP
signal intensity of BM KSL cells in each group (n = 21–30, t test; all panels, mean
1592 Cell Reports 17, 1584–1594, November 1, 2016at a 1:50 dilution for 30 min. For pS6K staining, cells were incubated with anti-
rabbit IgG PE (Cell Signaling Technology) at 1:500 for 30 min. Flow cytometry
analysis was performed on a FACS CANTO II (BD Biosciences).
Immunohistochemistry
H&E staining of femurs from mice was performed as previously described
(Himburg et al., 2014). Images were obtained using an Axiovert 200 micro-
scope (Carl Zeiss).
BrdU Incorporation, Cell Cycle Analysis, and Annexin V Analysis
For BrdU incorporation analysis, Grb10m/+ mice or Grb10+/+ mice were in-
jected intraperitoneally with 2 mg BrdU suspended in PBS. At 24 hr, BM cells
were collected and stained with anti-BrdU FITC (Becton Dickinson [BD]). For
cell cycle analysis, BM cells were flushed into PBS plus 10% fetal bovine
serum (FBS) and stained for surface c-kit, sca-1, and lineage markers for
30 min. Cells were then fixed with buffer III (BD) for 30 min, followed by incu-
bation of permeabilization buffer (BD). Anti-Ki67 FITC (BD) was added to the
cells and incubated for 30 min. 7AAD was added to stain for DNA content.
For analysis of HSC apoptosis in Grb10m/+ mice or Grb10+/+ mice, BM cells
were stained with anti-c-kit, anti-sca-1, and anti-lineage antibodies for
30 min, followed by the application of the FITC Annexin V Apoptosis Detection
Kit I (BD), as previously described (Quarmyne et al., 2015). For in vivo analyses,
mice were irradiated with 700 cGy to allow sensitive detection of radiation ef-
fects on cell cycle or cell death in BM KSL cells. For in vitro cell cycle and
apoptosis assays, BM KSL cells were sorted into a 96-well plate using a BD
FACS Aria sorter. KSL cells were irradiated at 300 cGy in vitro. At certain
time points after irradiation, cells were collected and cell cycle and apoptosis
assays were performed.
Homing Assay
The 23 104 BMSca-1+lin cells (CD45.2+) were injected into lethally irradiated
B6.SJL recipients (CD45.1+), and donor cell engraftment was measured by
flow cytometry at 18 hr after transplantation, as previously described (Quar-
myne et al., 2015).
Senescence Assay
Grb10m/+ and Grb10+/+ mice were irradiated with 700 cGy TBI using a Cs 137
irradiator. At 24 hr following irradiation, BM cells were isolated from both
groups in cold PBS containing 2% FBS. Senescent cells were stained for
senescence-activated b-galactosidase using the Quantitative Cellular Senes-
cence Assay Kit (Cell Biolabs) and analyzed on a BD CANTO II (BD
Biosciences).
mTOR and Akt Inhibition Experiments
For in vivo inhibition of mTORC1, temsirolimus (CCI-779, Selleckchem) was re-
constituted in ethanol at 10 mg/mL and then diluted in 5% Tween-80 (Sigma-
Aldrich) and 5%polyethylene glycol (PEG) 400 (Hampton Research).Grb10m/+
mice andGrb10+/+ mice were irradiated at 550 cGy at day 0, then injected with
CCI-779 (10 mg/kg intraperitoneally) or vehicle every other day through
day +10. At day +10, BM cells were isolated from irradiated Grb10m/+ mice
and Grb10+/+ mice and stained for SLAM+KSL cells. For in vivo inhibition of
Akt, MK2206 (Selleckchem) was reconstituted in 30% Captisol (Sigma-
Aldrich). Grb10m/+ mice and Grb10+/+ mice were irradiated at 550 cGy at
day 0, then orally administeredwithMK2206 (120mg/kg) or vehicle every other
day through day +10. At day +10, BM cells were isolated from irradiated
Grb10m/+ mice and Grb10+/+ mice and stained for SLAM+KSL cells.
Real-Time qPCR
RNA was isolated using the QIAGEN RNeasy micro kit. RNA was reverse tran-
scribed into cDNA using iScript cDNA synthesis kit. The qRT-PCR analysis fort or no SCF treatment for 3 days show an enhanced response in BM KSL cells
) show the binding of Grb10 and c-kit proteins via PLA in BM KSL cells from
I; red, Grb10-c-kit complex. Right: scatterplot shows the mean fluorescence
s ± SEM). See also Figures S2 and S3.
STAT5b, LMX1a, Grb10, p16, p21, p18, p27, p57, CDK2, CDK4, Cyclin D, and
Cyclin E was performed using Taqman Gene Expression assays.
PLA
For the detection of binding between Grb10 and c-kit, a PLA was performed
using the Duolink In Situ Red Starter Kit (Sigma-Aldrich). BM KSL cells
from Grb10m/+ and Grb10+/+ mice were sorted by FACS and treated with
100 ng/mL SCF or saline for 15 min at 37C. Cells were then fixed in 4% para-
formaldehyde (PFA) for 20 min on a slide and incubated with rabbit anti-Grb10
(Abcam) and goat anti-c-kit antibodies (R&DSystems) overnight. PLAwas per-
formed by the addition of species-specific secondary antibodies (goat and
rabbit) with PLUS and MINUS oligonucleotide probes from the Duolink kit.
Binding of the PLUS and MINUS oliogonucleotide probes only occurs when
the two proteins of interest are in close proximity, and it results in a high-inten-
sity dsRed fluorescent signal. Slides were then counterstained with DAPI to
visualize cell nuclei and enable enumeration of total cells. Images were
captured using an Axiovert 200 fluorescent microscope (Carl Zeiss) and pro-
cessed with ImageJ software. The DAPI channel was used to establish the
boundaries of individual cells. The fluorescence intensity of the DuoLink signal
was then quantified in the dsRed channel by integrating the fluorescence in-
tensity within each cell boundary. Isolated single pixels on the image were
removed to filter noise. Results were exported into Excel and analyzed by
GraphPad Prism 6.
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